Loteprednol

Category: Anti-Inflammatory



Loteprednol Overview

Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax[1] and Loterex. It was patented in 1980 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Fu...

Read more Loteprednol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Loteprednol

Recent Loteprednol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Loteprednol
  • Gel: 0.38%, 0.5%
  • Ointment: 0.5%
  • Suspension: 0.2%, 0.5%
  • Suspension/drops: 0.2%, 0.20%, 0.5%, 0.50%, 1%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Loteprednol: (1 result)

Sorted by National Drug Code
  • 68682-299 Loteprednol Etabonate 5 mg/ml Ophthalmic Suspension/ Drops by Oceanside Pharmaceuticals

Other drugs which contain Loteprednol or a similar ingredient: (6 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA